TMCnet News
Research and Markets: Cellular Therapy in Oncology Drug Pipeline Update 2015 - 101 companies plus partners developing 120 cellular therapy drugs in 252 developmental projectsResearch and Markets (http://www.researchandmarkets.com/research/t9q6nx/cellular_therapy) has announced the addition of the "Cellular Therapy in Oncology Drug Pipeline Update 2015" report to their offering. There are today 101 companies plus partners developing 120 cellular therapy drugs in 252 developmental projects in cancer. In addition, there are 6 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 65 drugs. Cellular Therapy In Oncology Drug Pipeline Update ists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 59 different targets. All included targets have been cross-referenced for the presence of mutations associated with human cancer. To date 54 out of the 55 studied drug targets so far have been recorded with somatic mutations. The software application lets you narrow in on these mutations and links out to the mutational analysis for each of the drug targets for detailed information. All drugs targets are further categorized on in the software application by 21 classifications of molecular function and with pathway referrals to BioCarta, KEGG, NCI-Nature and NetPath. Pipeline Breakdown According to Number of Drugs
Delivery Format: Desktop App plus Online Access to Updates (One Year) For more information visit http://www.researchandmarkets.com/research/t9q6nx/cellular_therapy
|
